This activity is supported by an educational grant from Merck & Co.

Immunotherapy: Advances and Updates

Anthony J. Olszanski, MD, RPH
Fox Chase Cancer Center

Laura J. Zitella, MS, RN, ACNP-BC, AOCN®
Stanford Cancer Institute

One of the greatest advances in oncology over the past decade has been the recognition of cell surface proteins that are shown to play a key role in tumor immunogenicity; mechanisms in which tumors are able to avoid immune surveillance and destruction. Although immunotherapy is a relatively new approach to anti-cancer treatment, it is being utilized across multiple tumor types. This program highlights the science behind immunotherapy, immune-related adverse side effects (irAEs), monitoring and managing irAEs, the role of biomarkers, and differentiating pseudo-progression from actual disease progression.


Download Podcast

   To claim credit for podcast click here

Download Transcript


Download Slides


Download Slides & Transcripts

   To claim credit for the slides & transcript click here

These CE/CME/CEU accredited activities are jointly provided by

JADPRO Logo    Harborside Press Logo    APSHO Logo    Annenberg Logo
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here